Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FV92B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,999
Award facts
- Contract value 100% obligated
- $15,998.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $16,000 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 28, 2025, with an ultimate completion date of October 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle extending through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen's federal contract portfolio demonstrates extensive pharmaceutical distribution capabilities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded contracts with firm fixed pricing reflects its established capability to meet federal procurement requirements and fulfill critical medical supply needs for military and veteran healthcare operations. This particular delivery order for Eliquis, an anticoagulant medication, represents a routine fulfillment of medical supply requirements under the broader DLA pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DB26FV92B?
SPE2DB26FV92B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FV92B worth?
The government has obligated $15,999 on SPE2DB26FV92B.
Is contract SPE2DB26FV92B an order under another contract?
Yes. SPE2DB26FV92B is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB26FV92B competed?
The extent of competition for SPE2DB26FV92B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award